Literature DB >> 7728035

Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study.

S A Grover1, I Lowensteyn, K L Esrey, Y Steinert, L Joseph, M Abrahamowicz.   

Abstract

OBJECTIVE: To evaluate the ability of doctors in primary care to assess risk patients' risk of coronary heart disease.
DESIGN: Questionnaire survey.
SETTING: Continuing medical education meetings, Ontario and Quebec, Canada.
SUBJECTS: Community based doctors who agreed to enroll in the coronary health assessment study. MAIN OUTCOME MEASURE: Ratings of coronary risk factors and estimates by doctors of relative and absolute coronary risk of two hypothetical patients and the "average" 40 year old Canadian man and 70 year old Canadian woman.
RESULTS: 253 doctors answered the questionnaire. For 30 year olds the doctors rated cigarette smoking as the most important risk factor and raised serum triglyceride concentrations as the least important; for 70 year old patients they rated diabetes as the most important risk factor and raised serum triglyceride concentrations as the least important. They rated each individual risk factor as significantly less important for 70 year olds than for 30 year olds (all risk factors, P < 0.001). They showed a strong understanding of the relative importance of specific risk factors, and most were confident in their ability to estimate coronary risk. While doctors accurately estimated the relative risk of a specific patient (compared with the average adult) they systematically overestimated the absolute baseline risk of developing coronary disease and the risk reductions associated with specific interventions.
CONCLUSIONS: Despite guidelines on targeting patients at high risk of coronary disease accurate assessment of coronary risk remains difficult for many doctors. Additional strategies must be developed to help doctors to assess better their patients' coronary risk.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7728035      PMCID: PMC2549361          DOI: 10.1136/bmj.310.6985.975

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  28 in total

1.  Cholesterol: consensus and controversy.

Authors:  A L Linton
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

2.  Therapeutic priorities of Canadian internists.

Authors:  A Laupacis; D L Sackett; R S Roberts
Journal:  CMAJ       Date:  1990-02-15       Impact factor: 8.262

Review 3.  Passive smoking and heart disease. Epidemiology, physiology, and biochemistry.

Authors:  S A Glantz; W W Parmley
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

4.  An updated coronary risk profile. A statement for health professionals.

Authors:  K M Anderson; P W Wilson; P M Odell; W B Kannel
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

5.  Attitudes and practices of primary care physicians in the management of elevated serum cholesterol levels.

Authors:  N R Langner; P D Hasselback; G C Dunkley; S J Corber
Journal:  CMAJ       Date:  1989-07-01       Impact factor: 8.262

6.  Physicians' perceptions of their role in cardiovascular risk reduction.

Authors:  K V Mann; R W Putnam
Journal:  Prev Med       Date:  1989-01       Impact factor: 4.018

7.  Early detection and treatment of hyperlipidemia: physician practices in Canada.

Authors:  T N Tannenbaum; J S Sampalis; R N Battista; E R Rosenberg; L Joseph
Journal:  CMAJ       Date:  1990-11-01       Impact factor: 8.262

8.  Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. The case of cholestyramine.

Authors:  G Oster; A M Epstein
Journal:  JAMA       Date:  1987-11-06       Impact factor: 56.272

9.  Internists' practices in health promotion and disease prevention. A survey.

Authors:  J S Schwartz; C E Lewis; C Clancy; M S Kinosian; M H Radany; J P Koplan
Journal:  Ann Intern Med       Date:  1991-01-01       Impact factor: 25.391

10.  Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia.

Authors:  B P Kinosian; J M Eisenberg
Journal:  JAMA       Date:  1988-04-15       Impact factor: 56.272

View more
  47 in total

1.  Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment.

Authors:  D M Pickin; C J McCabe; L E Ramsay; N Payne; I U Haq; W W Yeo; P R Jackson
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

2.  Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men.

Authors:  I U Haq; L E Ramsay; W W Yeo; P R Jackson; E J Wallis
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

3.  Comparative evaluation of the new Sheffield table and the modified joint British societies coronary risk prediction chart against a laboratory based risk score calculation.

Authors:  K S Rabindranath; N R Anderson; R Gama; M R Holland
Journal:  Postgrad Med J       Date:  2002-05       Impact factor: 2.401

4.  Diagnostic classification in patients with suspected deep venous thrombosis: physicians' judgement or a decision rule?

Authors:  Geert-Jan Geersing; Kristel J Janssen; Ruud Oudega; Henk van Weert; Henri Stoffers; Arno Hoes; Karel Moons
Journal:  Br J Gen Pract       Date:  2010-10       Impact factor: 5.386

5.  Cardiovascular disease. Physician attitudes toward prevention and treatment.

Authors:  A M Grant; T Niyonsenga; I Dion; E Delisle; M Xhignesse; R Bernier
Journal:  Can Fam Physician       Date:  1998-04       Impact factor: 3.275

6.  Assessing heart disease risk in primary care. Cholesterol lowering should be just one part of a multiple risk factor intervention.

Authors:  T Fahey
Journal:  BMJ       Date:  1998-10-24

Review 7.  Urgency and priority for cardiac surgery: a clinical judgment analysis.

Authors:  F Kee; P McDonald; J R Kirwan; C C Patterson; A H Love
Journal:  BMJ       Date:  1998-03-21

Review 8.  Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians.

Authors:  Stacey Sheridan; Michael Pignone; Cynthia Mulrow
Journal:  J Gen Intern Med       Date:  2003-12       Impact factor: 5.128

9.  Do clinicians recommend aspirin to patients for primary prevention of cardiovascular disease?

Authors:  Kevin Fiscella; Paul C Winters; Michael Mendoza; Gary J Noronha; Carlos M Swanger; John D Bisognano; Robert J Fortuna
Journal:  J Gen Intern Med       Date:  2015-02       Impact factor: 5.128

Review 10.  Subclinical cardiovascular disease assessment in persons with diabetes.

Authors:  Haider Javed Warraich; Khurram Nasir
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.